Learn About Diabetic Macular Edema (DME)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Sobha Sivaprasad practices in London, United Kingdom. Sivaprasad is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Their top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.
Ursula Erfurth-Schmidt practices in Vienna, Austria. Ms. Erfurth-Schmidt is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.
Mark Gillies practices in Sydney, Australia. Mr. Gillies is rated as an Elite expert by MediFind in the treatment of Diabetic Macular Edema (DME). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Cataract Removal, and Vitrectomy.
Summary: This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1-4) and Phase II (Part 5). Phase I investigated the safety of RO7446603 following a single and multiple intravitreal (IVT) doses as monotherapy or co-administered with IVT aflibercept or IVT faricimab...
Summary: The Farseeing Study will explore long-term effectiveness, safety, and treatment patterns among patients being treated with faricimab in real-world, routine clinical practice in China. It is a primary data collection, non-interventional, prospective and retrospective, multi-center study designed to collect real-world, long-term data to gain clinical evidence on faricimab, by observing cohorts of pa...